ALAN FINKEL: Open Payments
NPI 1114098530 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,089 in 91 payments from 12 companies in 2025. Trend: 2023 $4,480 · 2024 $11,702 · 2025 $11,089
Consulting: $8,450Food & beverage: $1,968Travel & lodging: $671
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $10,223 |
| PFIZER INC. | 14 | $287 |
| Lundbeck LLC | 9 | $152 |
| Impel Pharmaceuticals LLC | 5 | $105 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Tonix Medicines, Inc. | 1 | $30 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
Products named: QULIPTA, BOTOX, NURTEC ODT, VYEPTI, TRUDHESA, Symbravo, XIFAXAN, UBRELVY.
Industry payments across NC — which companies pay providers there.
